Matthew Dyer

1.1k total citations
22 papers, 769 citations indexed

About

Matthew Dyer is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Matthew Dyer has authored 22 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Matthew Dyer's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Ovarian cancer diagnosis and treatment (4 papers) and BRCA gene mutations in cancer (3 papers). Matthew Dyer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Ovarian cancer diagnosis and treatment (4 papers) and BRCA gene mutations in cancer (3 papers). Matthew Dyer collaborates with scholars based in United Kingdom, Canada and Australia. Matthew Dyer's co-authors include Linda Sharples, Martin Buxton, Kimberley Goldsmith, Jeni Warburton, Anthony Bentley, Johanna Armstrong, Angela George, A. A. Klein, Samer A.M. Nashef and Alain Vuylsteke and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Anesthesia & Analgesia.

In The Last Decade

Matthew Dyer

22 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Dyer United Kingdom 13 268 223 161 95 82 22 769
Dhruv Mahtta United States 18 500 1.9× 115 0.5× 347 2.2× 77 0.8× 105 1.3× 69 1.0k
Frank Verheyen Germany 16 374 1.4× 149 0.7× 140 0.9× 199 2.1× 73 0.9× 53 1.2k
Lauren Gilstrap United States 14 350 1.3× 203 0.9× 96 0.6× 226 2.4× 71 0.9× 44 916
Powell Jose United States 10 581 2.2× 61 0.3× 202 1.3× 113 1.2× 104 1.3× 18 1.2k
Josephine Sollano United States 4 499 1.9× 138 0.6× 145 0.9× 142 1.5× 46 0.6× 5 802
Nishant Shah United States 17 485 1.8× 63 0.3× 283 1.8× 58 0.6× 89 1.1× 71 1.1k
Lazaros Andronis United Kingdom 17 80 0.3× 173 0.8× 264 1.6× 118 1.2× 210 2.6× 57 1.1k
Bruce Weaver Canada 15 125 0.5× 175 0.8× 331 2.1× 180 1.9× 197 2.4× 30 1.5k
L Parsons United Kingdom 6 281 1.0× 129 0.6× 199 1.2× 71 0.7× 110 1.3× 8 836
Courtney Kennedy Canada 22 137 0.5× 242 1.1× 671 4.2× 150 1.6× 75 0.9× 46 1.8k

Countries citing papers authored by Matthew Dyer

Since Specialization
Citations

This map shows the geographic impact of Matthew Dyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Dyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Dyer more than expected).

Fields of papers citing papers by Matthew Dyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Dyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Dyer. The network helps show where Matthew Dyer may publish in the future.

Co-authorship network of co-authors of Matthew Dyer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Dyer. A scholar is included among the top collaborators of Matthew Dyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Dyer. Matthew Dyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dyer, Matthew, et al.. (2020). The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer. Health Economics Review. 10(1). 10–10. 1 indexed citations
3.
Dyer, Matthew, et al.. (2020). Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops. International Journal of Technology Assessment in Health Care. 36(2). 104–112. 13 indexed citations
4.
5.
Dyer, Matthew, Matthew Green, Simon W. Jones, & Rachel Hodge. (2019). Estimating long-term survival of previously untreated patients with EGFR mutation-positive (EGFRm) advanced non-small cell lung cancer (NSCLC) who received osimertinib in the FLAURA study.. Journal of Clinical Oncology. 37(15_suppl). e20560–e20560. 1 indexed citations
6.
Bentley, Anthony, et al.. (2017). A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer. Value in Health. 20(4). 567–576. 53 indexed citations
7.
Greystoke, Alastair, et al.. (2017). Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer. Journal of Medical Economics. 21(2). 113–121. 31 indexed citations
8.
9.
Mistry, Hema, Stephen Morris, Matthew Dyer, et al.. (2012). Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach. BMJ Open. 2(5). e001029–e001029. 27 indexed citations
10.
Bakerly, Nawar Diar, et al.. (2011). The effect of COPD health forecasting on hospitalisation and health care utilisation in patients with mild-to-moderate COPD. Chronic Respiratory Disease. 8(1). 5–9. 10 indexed citations
11.
Dyer, Matthew, Kimberley Goldsmith, Linda Sharples, & Martin Buxton. (2010). A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health and Quality of Life Outcomes. 8(1). 13–13. 326 indexed citations
12.
Goldsmith, Kimberley, Matthew Dyer, Martin Buxton, & Linda Sharples. (2010). Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Health and Quality of Life Outcomes. 8(1). 54–54. 39 indexed citations
13.
Stein, Ken, et al.. (2009). The precision of health state valuation by members of the general public using the standard gamble. Quality of Life Research. 18(4). 509–518. 6 indexed citations
14.
Goldsmith, Kimberley, Matthew Dyer, Peter M. Schofield, Martin Buxton, & Linda Sharples. (2009). Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health and Quality of Life Outcomes. 7(1). 96–96. 40 indexed citations
15.
Rogers, G, Ruth Garside, Stuart Mealing, et al.. (2008). Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas. PharmacoEconomics. 26(1). 33–44. 13 indexed citations
16.
Klein, A. A., Samer A.M. Nashef, Linda Sharples, et al.. (2008). A Randomized Controlled Trial of Cell Salvage in Routine Cardiac Surgery. Anesthesia & Analgesia. 107(5). 1487–1495. 55 indexed citations
17.
Sharples, Linda, Fay Cafferty, Carol Freeman, et al.. (2007). Evaluation of the Clinical Effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). The Journal of Heart and Lung Transplantation. 26(1). 9–15. 12 indexed citations
18.
Sharples, Linda, Matthew Dyer, Fay Cafferty, et al.. (2006). Cost-effectiveness of Ventricular Assist Device Use in the United Kingdom: Results From the Evaluation of Ventricular Assist Device Programme in the UK (EVAD-UK). The Journal of Heart and Lung Transplantation. 25(11). 1336–1343. 41 indexed citations
19.
Stein, Ken, et al.. (2006). A pilot Internet "Value of Health" Panel: recruitment, participation and compliance. Health and Quality of Life Outcomes. 4(1). 90–90. 11 indexed citations
20.
Warburton, Jeni & Matthew Dyer. (2004). OLDER VOLUNTEERS PARTICIPATING IN A UNIVERSITY RESEARCH REGISTRY: HELPING OTHERS MY AGE. Educational Gerontology. 30(5). 367–381. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dhruv Mahtta Breakdown of academic impact, for papers by Frank Verheyen Breakdown of academic impact, for papers by Lauren Gilstrap Breakdown of academic impact, for papers by Powell Jose Breakdown of academic impact, for papers by Josephine Sollano Breakdown of academic impact, for papers by Nishant Shah Breakdown of academic impact, for papers by Lazaros Andronis Breakdown of academic impact, for papers by Bruce Weaver Breakdown of academic impact, for papers by L Parsons Breakdown of academic impact, for papers by Courtney Kennedy
Rankless by CCL
2026